Piramal Pharma gets nod to sell unit in Thane

31 Jul 2024 Evaluate

Piramal Pharma has received approval to sell its unit comprising of a plot of land and factory premises situated at A-159, MIDC, Wagle Industrial Estate, Thane to Sankalpan Architects for a proposed consideration of around Rs 9 crore and for execution of a Memorandum of Understanding with the Buyer.

The Transaction is expected to be completed within 6 months, upon execution of definitive documents basis the terms & conditions thereof. The aforementioned Company’s unit is decommissioned and the sale has no impact on the operations of the Company. The details pertaining to amount and percentage of the turnover or revenue or income and net worth contributed by the unit during the last financial year is Nil.

Further, the Buyer does not belong to the promoter/promoter group/group companies and the Transaction does not fall under the ambit of Related Party Transaction. The administrative Committee of the Board of Directors of the Company at its meeting held on July 30, 2024 has approved the same. 

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Piramal Pharma Share Price

179.95 -0.60 (-0.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×